Spend 50 minutes in Singapore with author and adventure capitalist Jim Rogers, the Indiana Jones of Finance.

If you're feeling bewildered by the paper money crisis, join us with Michael MacDonald and Christopher Whitestone - the authors of The Silver Bomb - as we bring it back to square one with an eye firmly fixed on silver.

From her first interview for a job on Wall Street through her successful career as a trader and financial consultant, Terri Duhon (the author of How the Trading Floor Really Works) offers a fascinating look into the complex field of risk management.

Scott Patterson, Wall Street Journal staff reporter and author of The Quants, outlines the incredible and frightening paradigm of high frequency trading.

Bitcoin – an emerging peer-to-peer payment system, platform, and cryptocurrency – is taking the world by storm. Reggie Middleton joins us with Andreas Antonopolous, Dave Scotese, and Sam Guzik to crystallize our undertanding of Bitcoin, Crowdfunding, and “The Future of Money”.

We continue our exploration of precious metals and their value as real money throughout global systemic transition and the predicted failure of paper money. Join us with James Turk and learn what you can do to protect yourself when the money bubble pops!

Plum Village director Sister Chan Khong discusses peace, community, love, and kindness.

Artist, Icelandic MP, and political activist Birgitta Jonsdottir joins us for an in-depth discussion of internet privacy, freedom of speech, and the opportunities before Iceland today.

LEAP director, former MI5 agent, and whistleblower Annie Machon answers difficult questions that get to the heart of a global surveillance culture and a military industrial complex whose ramifications are difficult to imagine.

John Davis, the CEO of the Northwest Patient Resource Center (NWPRC), is at the heart of the burgeoning cannabis industry in the United States. As the reality of marijuana legalization takes root in the U.S., John discusses the issues and the fine points of stewarding a massive drug policy change in the United States.